SEC Company Response from Alector, (ALEC) — Jan 27, 2020
Alector, Inc.
Date: Jan. 27, 2020 · CIK: 0001653087 · Accession: 0001193125-20-015374
AI Filing Summary & Sentiment
File numbers found in text: 333-236094
Show Raw Text
CORRESP 1 filename1.htm CORRESP January 27, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Chris Edwards Re: Alector, Inc. Registration Statement on Form S-1 (File No. 333-236094) Acceleration Request Requested Date: Wednesday, January 29, 2020 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Alector, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-l (File No. 333-236094) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Michael E. Coke at (650) 565-3596 or Melissa S. Rick at (650) 849-3059. [Signature page follows] Sincerely, ALECTOR, INC. /s/ Arnon Rosenthal Arnon Rosenthal, Ph.D. Chief Executive Officer Enclosures cc (w/o enclosures): Stephanie Yonker, Ph.D., Alector, Inc. Kenneth A. Clark, Wilson Sonsini Goodrich & Rosati, P.C. Michael E. Coke, Wilson Sonsini Goodrich & Rosati, P.C. Melissa S. Rick, Wilson Sonsini Goodrich & Rosati, P.C. Alan F. Denenberg, Davis Polk & Wardwell LLP Stephen Salmon, Davis Polk & Wardwell LLP